PeptideDB

Histone acetyltransferase p300 Inhibitor 4c

CAS No.: 2103-99-3

Histone acetyltransferase p300 Inhibitor 4c is a 2-aminothiazole derivative. Histone acetyltransferase p300 Inhibitor 4c
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Histone acetyltransferase p300 Inhibitor 4c is a 2-aminothiazole derivative. Histone acetyltransferase p300 Inhibitor 4c inhibited hCA I, hCA II, AChE and BChE with Ki values of 0.008 ± 0.001, 0.124 ± 0.017, 0.129 ± 0.030 and 0.083 ± 0.041 µM. 0.017, 0.129 ± 0.030 and 0.083 ± 0.041 μM.
molecular weight 210.68
Molecular formula C9H7ClN2S
CAS 2103-99-3
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Solubility DMSO: 50 mg/mL (237.33 mM)
References 1. Caba-Flores MD, et al. Activity In Vitro of 2-Chloro-N-[4-(4-Chlorophenyl)-2-Thiazolyl]Acetamide Against Promastigotes of Leishmania mexicana: An Apoptosis Inducer. Acta Parasitol. 2021;66(3):1068-1073. 2. Ryu EK, et al. Curcumin and dehydrozingerone derivatives: synthesis, radiolabeling, and evaluation for beta-amyloid plaque imaging. J Med Chem. 2006;49(20):6111-6119. 3. Burmudžija AZ, et al. Cytotoxic and Antimicrobial Activity of Dehydrozingerone based Cyclopropyl Derivatives. Chem Biodivers. 2017;14(8):10.1002/cbdv.201700077.